CORONAVIRUS/Adimmune to launch COVID-19 vaccine clinical trials in Indonesia

12/20/2021 09:37 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, Dec. 20 (CNA) Taiwanese vaccine maker Adimmune Corp. will launch clinical trials for its COVID-19 vaccine candidate in Indonesia early next year, with initial results expected in mid-2022, as it seeks to tap into the Muslim market by obtaining halal certification, the company announced on Monday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.